• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » CBT Moderately Effective in Improving Quality of Life for Anxiety Disorders

CBT Moderately Effective in Improving Quality of Life for Anxiety Disorders

September 1, 2014
Glen Spielmans, PhD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.

Subject:
Anxiety Disorders

Short Description:

CBT Moderately Effective in Improving Quality of Life for Anxiety Disorders

Background:

Cognitive behavioral therapy (CBT) has been shown to be effective in reducing the symptoms of anxiety disorders. But there’s not a lot of information about whether it improves patients’ quality of life (QoL), even though one would think improvement in QoL is inherent when anxiety is reduced.

A recent meta-analysis looked at 44 studies, including 59 CBT trials involving 3,326 participants who received CBT for a variety of anxiety disorders, to determine the effects of the treatment on QoL.

The meta-analysis concluded that CBT has a beneficial effect on QoL, especially when it is provided face-to-face, either individually or in groups, as opposed to online. Researchers found improvements were greater for physical (ie, energy, pain, sleep) and psychological (ie, emotions, self-esteem, cognition, bodily image) domains of QoL than for environmental (ie, finances, safety/security, participation in recreation, etc.) and social (ie, personal relationships, social support, sexual activity) domains.

The overall effect on QoL increased with the duration of treatment, suggesting brief treatments may not achieve the desired outcome, although the research did not identify an “ideal” length of treatment. While symptoms of anxiety might respond within only a few sessions, longer treatment may be necessary to noticeably improve a patient’s QoL.

Of the 59 clinical trials, 22 provided individual CBT delivered face-to-face, 14 provided group CBT delivered face-to-face, and 23 delivered CBT via the Internet. The face-to-face treatments delivered individually and in groups to patients produced significantly higher effect sizes on QoL than Internet-delivered treatments (Hofmann SG et al, J Consult Clin Psychol 2014;82(3):375–391).

TCPR’s Take: These findings support the use of CBT to enhance QoL in a wide range of anxiety disorders. This meta-analysis, however, did not compare CBT to medication management, nor did it compare the effectiveness of CBT on QoL among different anxiety disorders. Effect sizes for in-person treatments were greater than those for online treatments, but head-to-head trials comparing the two types of treatment are lacking.

General Psychiatry
KEYWORDS anxiety_disorder cognitive_behavioral_therapy research_updates
    Ccpr octnovdec2020 qa1 headshot spielmans 150x150
    Glen Spielmans, PhD

    L-Methylfolate May Offer Modest Boost to Antidepressants

    More from this author
    www.thecarlatreport.com
    Issue Date: September 1, 2014
    SUBSCRIBE NOW
    Table Of Contents
    Step Right Up—Meaningful Use Incentives are Adding Up
    Op-Ed: Maintenance of Certification—Is it safe to opt out?
    Maintenance of Certification: What You Need to Know
    Using Transcranial Magnetic Stimulation (TMS) in Your Practice
    Mood Stabilizer Plus Antidepressant May Protect Against Mania
    CBT Moderately Effective in Improving Quality of Life for Anxiety Disorders
    Another Sleeping Pill on the Market: Merck’s Belsomra
    Should We Share Therapy Notes with Our Patients?
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.